文献速递心血管MR

基于负荷灌注心脏磁共振诊断的冠状动脉微血管疾病患者的长期预后

Long-Term Prognosis of Patients With Coronary Microvascular Disease Using Stress Perfusion Cardiac Magnetic Resonance.
PubMed 文献 · JACC Cardiovasc Imaging · 2020-11-25

该回顾性多中心研究纳入218例有缺血症状但无显著冠脉狭窄的患者,用负荷灌注心脏磁共振测量心肌灌注储备指数(MPRI),中位随访5.5年,发现MPRI≤1.47者主要不良心血管事件风险是MPRI>1.47者的3.14倍,MPRI为独立预测因子。

要点

  • 负荷灌注心脏磁共振测量的MPRI≤1.47提示MACE风险增高约3倍。
  • MPRI是缺血症状但无阻塞性冠脉疾病患者MACE的独立预测因子。
  • 诊断微血管心绞痛的MPRI阈值为<1.4,预测MACE的最佳阈值为≤1.47。

核心结论

  • 负荷灌注心脏磁共振衍生的MPRI是预测缺血症状且无显著冠脉疾病患者中期MACE的独立影像标志物。

研究设计与样本

  • 回顾性研究,纳入2009年1月至2017年12月香港3个影像中心因胸痛就诊、无心外膜冠脉疾病或心肌疾病的患者218例。
  • 负荷灌注心脏磁共振使用腺苷或三磷酸腺苷,以脾脏开关征评估负荷是否充分,所有扫描均测量MPRI。
  • 随访主要不良心血管事件,定义为全因死亡、急性冠脉综合征、心外膜冠脉疾病进展、心力衰竭住院和非致命性卒中。

诊断标准与关键数值

  • 诊断微血管心绞痛的MPRI阈值为<1.4。
  • 预测MACE的最佳MPRI截断值为≤1.47。
  • MPRI≤1.47者MACE风险较MPRI>1.47者增加3倍(HR 3.14,95%CI 1.58–6.25,P=0.001)。
  • 校正年龄和高血压后,MPRI为MACE的独立预测因子(HR 0.10,95%CI 0.03–0.34,P<0.001)。

临床应用与阅片要点

  • 在缺血症状但无阻塞性冠脉疾病的患者中,可测量MPRI并以≤1.47识别MACE高危者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study investigated the prognosis of coronary microvascular disease (CMD) as determined by stress perfusion cardiac magnetic resonance (CMR) in patients with ischemic symptoms but without significant coronary artery disease (CAD).

BACKGROUND: Patients with CMD have poorer prognosis with various cardiac diseases. The myocardial perfusion reserve index (MPRI) derived from noninvasive stress perfusion CMR has been established to diagnose microvascular angina with a threshold MPRI <1.4. The prognosis of CMD as determined by MPRI is unknown.

METHODS: Chest pain patients without epicardial CAD or myocardial disease from January 2009 to December 2017 were retrospectively included from 3 imaging centers in Hong Kong (HK). Stress perfusion CMR examinations were performed using either adenosine or adenosine triphosphate. Adequate stress was assessed by achieving splenic switch-off sign. Measurement of MPRI was performed in all stress perfusion CMR scans. Patients were followed for major adverse cardiovascular events defined as all-cause death, acute coronary syndrome (ACS), epicardial CAD development, heart failure hospitalization and non-fatal stroke.

RESULTS: A total of 218 patients were studied (mean age 59 ± 12 years; 49.5% male) and the average MPRI of that cohort was 1.56 ± 0.33. Females and a history of hyperlipidemia were predictors of lower MPRI. Major adverse cardiovascular events (MACE) occurred in 15.6% of patients during a median follow-up of 5.5 years (interquartile range: 4.6 to 6.8 years). The optimal cutoff value of MPRI in predicting MACE was found with a threshold MPRI ≤1.47. Patients with MPRI ≤1.47 had three-fold increased risk of MACE compared with those with MPRI >1.47 (hazard ratio [HR]: 3.14; 95% confidence interval [CI]: 1.58 to 6.25; p = 0.001). Multivariate Cox regression after adjusting for age and hypertension demonstrated that MPRI was an independent predictor of MACE (HR: 0.10; 95% CI: 0.03 to 0.34; p < 0.001).

CONCLUSIONS: Stress perfusion CMR-derived MPRI is an independent imaging marker that predicts MACE in patients with ischemic symptom and no overt CAD over the medium term.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Zhou W, Lee JCY, Leung ST, et al. Long-Term Prognosis of Patients With Coronary Microvascular Disease Using Stress Perfusion Cardiac Magnetic Resonance. JACC Cardiovasc Imaging. 2020. PMID: 33248966. doi:10.1016/j.jcmg.2020.09.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。